Literature DB >> 32172471

Parkinson's disease treatment: past, present, and future.

John D Elsworth1.   

Abstract

The substantial contributions of Dr. Gerald Stern to past and current treatments for Parkinson's disease patients are reviewed, which form the foundation for an evaluation of future options to control symptoms and halt progression of the disease. These opportunities will depend on a greater understanding of the relative contributions of the environment, genetic and epigenetic influences to disease onset, and promise to emerge as strategies for improving mitochondrial function, halting accumulation of synuclein and neuromelanin, in addition to refinement of stem cell and gene therapies. Such advances will be achieved through deployment of improved models for the disease.

Entities:  

Keywords:  Gene therapy; Parkinson’s disease; Pathology; Pharmacology; Review; Stem cells

Mesh:

Year:  2020        PMID: 32172471      PMCID: PMC8330829          DOI: 10.1007/s00702-020-02167-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  82 in total

1.  The horse that wouldn't run.

Authors:  Gerald Stern
Journal:  Pract Neurol       Date:  2012-02

Review 2.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Authors:  Lucio G Costa; Rian de Laat; Khoi Dao; Claudia Pellacani; Toby B Cole; Clement E Furlong
Journal:  Neurotoxicology       Date:  2013-09-04       Impact factor: 4.294

3.  Susceptibility to a parkinsonian toxin varies during primate development.

Authors:  B A Morrow; R H Roth; D E Redmond; S Diano; J D Elsworth
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

4.  Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants.

Authors:  J Zhou; H F Bradford; G M Stern
Journal:  Brain Res Dev Brain Res       Date:  1997-05-20

5.  Letter: Lithium in Parkinson's disease.

Authors:  J A McCaul; G M Stern
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

6.  Combined treatment of parkinsonism with L-dopa and amantadine.

Authors:  K R Hunter; G M Stern; D R Laurence; P Armitage
Journal:  Lancet       Date:  1970-09-12       Impact factor: 79.321

Review 7.  Towards stem cell based therapies for Parkinson's disease.

Authors:  Malin Parmar
Journal:  Development       Date:  2018-01-08       Impact factor: 6.868

Review 8.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.

Authors:  Jeff M Bronstein; Michele Tagliati; Ron L Alterman; Andres M Lozano; Jens Volkmann; Alessandro Stefani; Fay B Horak; Michael S Okun; Kelly D Foote; Paul Krack; Rajesh Pahwa; Jaimie M Henderson; Marwan I Hariz; Roy A Bakay; Ali Rezai; William J Marks; Elena Moro; Jerrold L Vitek; Frances M Weaver; Robert E Gross; Mahlon R DeLong
Journal:  Arch Neurol       Date:  2010-10-11

9.  Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis.

Authors:  Chin-Hsiao Tseng
Journal:  J Clin Med       Date:  2018-09-27       Impact factor: 4.241

10.  MHC matching improves engraftment of iPSC-derived neurons in non-human primates.

Authors:  Asuka Morizane; Tetsuhiro Kikuchi; Takuya Hayashi; Hiroshi Mizuma; Sayuki Takara; Hisashi Doi; Aya Mawatari; Matthew F Glasser; Takashi Shiina; Hirohito Ishigaki; Yasushi Itoh; Keisuke Okita; Emi Yamasaki; Daisuke Doi; Hirotaka Onoe; Kazumasa Ogasawara; Shinya Yamanaka; Jun Takahashi
Journal:  Nat Commun       Date:  2017-08-30       Impact factor: 14.919

View more
  4 in total

1.  Photobiomodulation for Parkinson's Disease in Animal Models: A Systematic Review.

Authors:  Farzad Salehpour; Michael R Hamblin
Journal:  Biomolecules       Date:  2020-04-15

Review 2.  Extracellular Vesicles in Liquid Biopsies: Potential for Disease Diagnosis.

Authors:  Jialing Liu; Ye Chen; Fang Pei; Chongmai Zeng; Yang Yao; Wen Liao; Zhihe Zhao
Journal:  Biomed Res Int       Date:  2021-01-11       Impact factor: 3.411

Review 3.  From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases.

Authors:  Yumeng Zhu; Ping Xu; Xuan Huang; Wen Shuai; Li Liu; Shuai Zhang; Rui Zhao; Xiuying Hu; Guan Wang
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

Review 4.  Development of early diagnosis of Parkinson's disease: Illusion or reality?

Authors:  Michael Ugrumov
Journal:  CNS Neurosci Ther       Date:  2020-06-29       Impact factor: 7.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.